Eli Lilly boss brands UK ‘worst country in Europe’ for cheap drug prices
Dave Ricks says Britain will miss out on medicines and future investment unless it pays more
Related reading
Eli Lilly not yet ready to unfreeze UK investments, says pharma boss
US drugmaker wants changes to types of drugs approved in Britain
Eli Lilly pushes for NHS drug price increases in return for its UK investment
US pharmaceutical group ‘optimistic’ about reaching deal with British government
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
US urged UK to offer better drug pricing deal to pharma companies
Ambassador’s meeting with chancellor Rachel Reeves came days before AstraZeneca and Merck paused projects in Britain
Big Pharma is falling out of love with Britain
Life sciences should be a natural place to look for growth
Eli Lilly raises UK price of weight-loss drug Mounjaro by up to 170%
Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines
